GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Heartseed Inc (TSE:219A) » Definitions » EBITDA Margin %

Heartseed (TSE:219A) EBITDA Margin % : -10.78% (As of Oct. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Heartseed EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Heartseed's EBITDA for the six months ended in Oct. 2024 was 円-77.7 Mil. Heartseed's Revenue for the six months ended in Oct. 2024 was 円720.4 Mil. Therefore, Heartseed's EBITDA margin for the quarter that ended in Oct. 2024 was -10.78%.


Heartseed EBITDA Margin % Historical Data

The historical data trend for Heartseed's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Heartseed EBITDA Margin % Chart

Heartseed Annual Data
Trend Oct22 Oct23 Oct24
EBITDA Margin %
-282.33 -420.12 -88.87

Heartseed Semi-Annual Data
Oct22 Oct23 Apr24 Oct24
EBITDA Margin % - - -456.04 -10.78

Competitive Comparison of Heartseed's EBITDA Margin %

For the Biotechnology subindustry, Heartseed's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Heartseed's EBITDA Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Heartseed's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Heartseed's EBITDA Margin % falls into.


;
;

Heartseed EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Heartseed's EBITDA Margin % for the fiscal year that ended in Oct. 2024 is calculated as

EBITDA Margin %=EBITDA (A: Oct. 2024 )/Revenue (A: Oct. 2024 )
=-776.354/873.61
=-88.87 %

Heartseed's EBITDA Margin % for the quarter that ended in Oct. 2024 is calculated as

EBITDA Margin %=EBITDA (Q: Oct. 2024 )/Revenue (Q: Oct. 2024 )
=-77.659/720.4
=-10.78 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Heartseed  (TSE:219A) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Heartseed EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Heartseed's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Heartseed Business Description

Traded in Other Exchanges
N/A
Address
1-2-3 Shibaura, Minato-ku, Tokyo, JPN, 105-0023
Heartseed Inc is engaged in developing and commercializing iPS cell-derived cardiomyocyte replacement therapy for advanced heart failure.

Heartseed Headlines

No Headlines